Journal & Article

Biochemistry & Molecular Biology

I/F
# Journal I/F

NATURE MEDICINE

Countering the impact of the climate crisis on health will require data. Every baby deserves access to genetic screening. What will it take to make precision health a global reality. Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist. Molecular pathology markers of FTD and ALS in blood extracellular vesicles. Women's health and rights in the twenty-first century. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial Turning the tide of early cancer detection How to bridge innovation and regulation for responsible AI in healthcare The search for authentic microbiome–disease relationships The efficacy of dapagliflozin in a hierarchical kidney outcome in heart failure Artificial intelligence in surgery Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children High-resolution African HLA resource uncovers HLA-DRB1expression effects underlying vaccine response Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results Continuous glucose monitoring and intrapersonal variability in fasting glucose Integrative multi-omics profiling in human decedents receiving pig heart xenografts Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging Vision–language foundation model for echocardiogram interpretation Microplastics are everywhere - we need to understand how they affect human health. How AI-powered handheld devices are boosting disease diagnostics - from cancer to dermatology. Food is medicine: clinical trials show the health benefits of dietary interventions. The European Network for IgE-Mediated Autoimmunity and Autoallergy (ENIGMA) initiative. To understand mRNA vaccine hesitancy, stop calling the public anti-science. Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis. Information is a determinant of health. Why diversity is needed at every level of clinical trials, from participants to leaders. Implementation of community screening strategies for depression. Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction. Promoting gender equity in the scientific and health workforce is essential to improve women's health. Functional precision medicine for pediatric cancers. Large language models for reducing clinicians' documentation burden. Using unlabeled data to enhance fairness of medical AI. Telehealth enables safe medication abortion in shifting health and legal contexts. Deciphering the genetic architecture of pain intensity. Testing pooled samples enables universal screening of congenital cytomegalovirus infection. Extreme weather events have lasting impacts on risk of death and healthcare utilization. Revealing clinical heterogeneity in a large brain bank cohort. Causal machine learning for predicting treatment outcomes. Targeting KRAS in cancer. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers. Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.